Rollins came into this Q3 2026 report with a premium P/E of 32.3x and a reputation as a dependable compounding pest control business. The share price then jumped 5.6% to US$35.31 in the first full session after the numbers hit, even though organic growth landed at 4.4% and management cut full year growth guidance to 4% to 6%. The real story is not a collapse in demand. It is pressure on profitability, with adjusted EBITDA of US$257 million and margin at 23.5% as the market tries to reconcile a high valuation with a softer earnings print.
Love Rollins' recurring pest control revenue but uneasy about paying a premium P/E for softer margins. Compare this setup with stocks in our list of solid balance sheet and fundamentals stocks (25 results).
Ask Charlie what AI search shift means for Rollins demand.
The upbeat story says Rollins can lean on acquisitions and higher quality channels while fixing residential digital weakness.
"Continued integration of Romex Pest Control and other recent tuck in deals, with management still targeting 2 to 3% annual revenue growth from acquisitions, could add to Rollins revenue and support earnings as these businesses are absorbed over time."
Q3 shows that M&A is contributing, with 6.2% headline growth and organic limited to 4.4%. Commercial and termite outpaced residential, which supports the mix shift idea. However, adjusted EBITDA margin at 23.5% and negative incremental margins show the earnings support piece is not landing cleanly.
The skeptical view worries that digital disruption and higher operating expenses will erode Rollins' economics faster than fixes can help.
"Market uncertainty and macroeconomic factors could lead to weakened demand trends, especially in the consumer facing residential business. This segment may already be seeing pressure, as brands like Orkin rely on consumer-initiated digital demand that has shifted to double digit declines in leads, and this could slow Rollins revenue growth and earnings."
Q3 outcomes fit that concern. Residential organic growth of 2.3% trails commercial, and management cut full year organic guidance to 4% to 6%. Weaker lead flow is now visible, and with gross margin compression plus higher SG&A, profitability is feeling the strain at the same time.
One Narrative disagrees with today's price. → See where this Narrative says Rollins should trade.
Rollins shows how a dependable business can still wrestle with margin pressure at a premium P/E. The real opportunity could sit in stocks that could be undervalued before the market closes the gap.
Those are three of them. See all 30 potentially undervalued companies →
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com